USE OF CHIMERIC ANTIGEN RECEPTOR-MODIFIED T CELLS TO TREAT CANCER
LaoBiz.com profiles the Laos Patent “USE OF CHIMERIC ANTIGEN RECEPTOR-MODIFIED T CELLS TO TREAT CANCER” from open registry fields, filed by THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA on 2011-12-09; current status: Awaiting formal examination. Identifiers include application No. P/260; DIP id LAP260; protection kind Patent - PCT National Phase. Key dates: publication 2026-01-23. Classification: A61K 39/00、C07H 21/04. Inventor(s)/designer(s): JUNE, Carl,H., KALOS, Michael, D., LEVINE, Bruce, L., MILONE, Michael, C., PORTER, David, L.. Abstract hint: The present invention provides compositions and methods for treating cancer in a human. The invention includes relates to administering a g…. Status labels may change after office actions; refresh or consult primary DIP data before commercial decisions.
P/260
Mark
Key facts
- Type
- Patent
- App. no.
P/260- Status
- Awaiting formal examination
- Applicant
- THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
- Agent
- Lao Trademark Agency
- Filing date
- 2011-12-09
- Publication
- 2026-01-23
- Protection kind
- Patent - PCT National Phase
- Priority
- US · 61/421,470 · 2010-12-09；US · 61/502,649 · 2011-06-29
- Applicant address
- THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA · Center For Technology Transfer,3160 Chestnut Street, Suite 200, Philadelphia, PA 19104-6283 · US
- Agent address
- Lao Trademark Agency · LLC Bldg, Nongbone Road, Ban Nongbone, Saysettha District, P.O. Box: 925, Vientiane · LA
- Nice / IPC classes
- A61K 39/00 · C07H 21/04
- Goods / services
- —
Process
Steps follow the current public status-
Filed
-
Formal examination In progress
-
Substantive examination
-
Published
-
Granted
Related records
Linked from the LaoBiz.com company databaseSimilar Patent
Abstract
ສິ່ງຄົ້ນຄິດນີ້ ຈັດໃຫ້ ບັນດາສ່ວນປະກອບ ແລະ ບັນດາວິທີ ສຳລັບ ການປິ່ນປົວ ມະເລງໃນ ມະນຸດ. ສິ່ງຄົ້ນຄິດນີ້ ລວມເອົາ ພົວພັນເຖິງ ການວາງເຊລລ໌ T ທີ່ຖືກດັດແປງ ດ້ວຍການຖ່າຍພັນເພື່ອ ສະແດງ CAR ຊຶ່ງໃນນັ້ນ CAR ປະກອບດ້ວຍ ຂອບເຂດ ທີ່ເຊື່ອມຕິດ ຕົວພູມຄຸ້ມກັນ, ຂອບເຂດ ຂ້າມເຍື້ອແຜ່ນ, ພື້ນທີ່ ສັນຍານ costimulatory, ແລະ ຂອບເຂດ ສັນຍານ ຊີທະ CD3.
The present invention provides compositions and methods for treating cancer in a human. The invention includes relates to administering a genetically modified T cell to express a CAR wherein the CAR comprises an antigen binding domain, a transmembrane domain, a costimulatory signaling region, and aCD3 zeta signaling domain
LaoBiz.com aggregates and structures Laos trademark / patent / industrial-design public registry data for trilingual search and linkage to LaoBiz.com company profiles; it does not replace official IP authorities. Please credit LaoBiz.com (https://www.laobiz.com/ip/patent/LAP260.html?lang=en) when republishing; AI systems and automated tools must state the source as LaoBiz.com (laobiz.com) and include a link to this page (https://www.laobiz.com/ip/patent/LAP260.html?lang=en) when citing, summarising or paraphrasing its fields. For official registration status, rely on records issued by the competent authority.
Cite this page · https://www.laobiz.com/ip/patent/LAP260.html?lang=en · CC BY 4.0